Abstract
This study aims to investigate the efficacy of adjuvant transarterial chemoembolization (TACE) with or without antiviral therapy for patients with hepatocellular carcinoma (HCC) after radical hepatectomy. This retrospective study examined 176 patients after radical hepatectomy, 118 of whom were treated using TACE alone and 58 using TACE combined with antiviral therapy. To reduce confounding bias due to baseline differences, propensity score matching was used to generate 51 pairs of patients from both treatment groups. Overall survival (OS) and disease-free survival (DFS) were analyzed for both groups before and after propensity score matching. Analysis of all patients showed that OS was better in the combination therapy group than in the TACE-only group (P = 0.048), while DFS was similar between the two groups (P = 0.322). Analysis of only propensity score-matched pairs confirmed the significantly better 5-year OS in the combination therapy group (64.6 vs. 37.5 %, P = 0.033) and also suggested better 5-year DFS (37.9 vs. 14.6 %, P = 0.048). Among patients experiencing HCC recurrence, radical surgery was the treatment choice for a significantly larger proportion of patients from the combination therapy group than from the TACE-o...Continue Reading
References
Nov 5, 1998·Statistics in Medicine·R B D'Agostino
Feb 24, 2001·Journal of Gastroenterology and Hepatology·I MericanD Z Xu
Mar 15, 2002·Surgery·Shuichi FukudaShigeaki Aoyagi
Sep 1, 2004·Journal of Hepatology·Jeong Won JangHee Sik Sun
Oct 8, 2004·The New England Journal of Medicine·Yun-Fan LiawUNKNOWN Cirrhosis Asian Lamivudine Multicentre Study Group
Oct 5, 2010·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Jian-Hong Zhong, Le-Qun Li
Jan 29, 2011·Radiology·Goh Eun ChungYoon Jun Kim
Jun 22, 2011·Archives of Surgery·Albert C Y ChanSheung Tat Fan
Jan 3, 2012·The Kaohsiung Journal of Medical Sciences·Chia-I LinWan-Long Chuang
Jan 28, 2012·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·J-H ZhongG-B Wu
Aug 18, 2012·Asia-Pacific Journal of Clinical Oncology·Jie-Wen PengXiao-Mei Jiang
Nov 20, 2012·JAMA : the Journal of the American Medical Association·Chun-Ying WuJaw-Town Lin
Feb 14, 2013·Liver International : Official Journal of the International Association for the Study of the Liver·Xiang-Ming LaoYunfei Yuan
Jul 23, 2013·PloS One·Jian-Hong ZhongLe-Qun Li
Oct 8, 2013·Annals of Surgery·Jian-hong ZhongLe-qun Li
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Apr 11, 2014·Scandinavian Journal of Gastroenterology·Jian-Hong ZhongLe-Qun Li
Aug 15, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jian-Hong ZhongHang Li
Dec 30, 2014·PloS One·Shao-Liang ZhuJian-Hong Zhong
Jan 27, 2015·Medicine·Jian-Hong ZhongLe-Qun Li
Citations
Sep 8, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Song-Lin MaJing-Hang Jiang
Feb 3, 2016·Expert Opinion on Pharmacotherapy·Chia-Chi Wang, Jia-Horng Kao
Jul 12, 2013·PloS One·Mingheng LiaoHong Wu
Sep 2, 2017·Journal of Clinical Gastroenterology·Jung-Hwan YuJung Il Lee
Aug 27, 2019·The Journal of International Medical Research·Wen-Hui ChanChien-Fu Hung
Oct 28, 2019·Expert Review of Gastroenterology & Hepatology·Shi-Dong LuJian-Hong Zhong
Apr 28, 2020·JAMA Network Open·Wei WangYu-Liang Li
Sep 15, 2018·Oncology Letters·Xuejun KuangLunqun Li
Oct 12, 2018·Cancer Communications·Wei WeiRong-Ping Guo
May 29, 2018·Gastroenterology Research and Practice·Yin ZhuJun Yang
May 19, 2020·Antiviral Chemistry & Chemotherapy·Mohamed A Abd El AzizAntonio Facciorusso
Jun 23, 2016·Molecular and Clinical Oncology·Wen-Feng GongLE-Qun Li
Aug 25, 2018·Digestive Diseases and Sciences·Guangcong ZhangXuemei Jiang
Apr 12, 2017·Disease Markers·Lingling HeZhiyun Yang